↓ Skip to main content
What is this page? Embed badge

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218…

Overview of attention for article published in Journal of Clinical Oncology, October 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs
1 blog
twitter
59 X users
guideline
1 clinical guideline source

Readers on

mendeley
66 Mendeley
So far, Altmetric has seen 1 blog post.
This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.